id: NEW:biomarker_feedback_intervention_to_hospitalization_past_year
name: Biomarker-Based Feedback Intervention for Alcohol Use â†’ Hospitalization Past Year
from_node:
  node_id: NEW:biomarker_feedback_intervention
  node_name: Biomarker-Based Feedback Intervention for Alcohol Use
to_node:
  node_id: hospitalization_past_year
  node_name: Hospitalization Past Year
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Routine care integrates biomarker-based advice for high-risk drinkers'
- 'Step 2: Early intervention reduces progression of alcohol-related health conditions'
- 'Step 3: Prevention of complications such as liver failure, pancreatitis, and alcohol withdrawal'
- 'Step 4: Reduced need for inpatient hospitalization for alcohol-related conditions'
- 'Step 5: Fewer hospital days and reduced healthcare system burden'
evidence:
  quality_rating: A
  n_studies: 16
  primary_citation: 'Mohsan Subhani et al. 2021. "Does Advice Based on Biomarkers of Liver Injury or Non-Invasive
    Tests of Liver Fibrosis Impact High-Risk Drinking Behaviour: A Systematic Review With Meta-analysis.."
    https://doi.org/10.1093/alcalc/agaa143'
  supporting_citations:
  - Studies included 14 randomized controlled trials and 2 observational studies (specific citations require
    full-text access)
  - Additional citations require full-text access for individual RCT details
  - Additional citations require full-text access for observational study details
  doi: 10.1093/alcalc/agaa143
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Non-intervention groups experienced more days spent in hospital compared to those receiving
  biomarker-based intervention advice, indicating reduced hospitalization burden with early intervention.
quantitative_effects:
  sample_size: 3763
structural_competency:
  equity_implications: This mechanism connects healthcare system organization to downstream resource utilization.
    Structural factors determining whether patients receive this intervention include healthcare system
    funding for screening programs, provider training, and integration of biomarker testing into primary
    care workflows. Disparities in healthcare access create differential exposure to this protective intervention.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.019259'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
